Aduro Biotech, Inc. (ADRO) has seen some recent action in the stock market and its common shares finished trading at $2.4900 yesterday. People are starting to take notice of ADRO as the common shares traded as high as $2.6500 and as low as $2.4800 in the last trading session.
Aduro Biotech, Inc. (ADRO) average trading volume is 530.93K. However, in the last trading session Aduro Biotech, Inc. (ADRO) traded 162,780 shares. The First downside support level on ADRO is $2.40 and the First resistance level on ADRO is $3.42. ADRO 50 day moving average is $2.7080 and ADRO 200day moving average is $2.7328.
Aduro Biotech, Inc. (ADRO) most current performance has been indicated by the recent movement in ADRO common shares. ADRO has performed -12.94% over the past 30 days, ADRO has performed 12.67% over the past quarter and ADRO has shown 99.20% over the past 1 year. Aduro Biotech, Inc. (ADRO) has a 12 month range of $0.9010 to $4.0400. Aduro Biotech, Inc. (ADRO) is trading 176.33% from its 12 month low and -38.37% from its 12 month high. Aduro Biotech, Inc. (ADRO) is showing a 5.79% short float showing the quantity short in the float.
ADRO has 80.86M shares outstanding and 56.97M shares in the float. Aduro Biotech, Inc. (ADRO) at this time has a market cap of $202.59M and income of -64.60M. The EPS next quarter for ADRO is -0.16 and projected EPS next year is -19.30%. The market cap of Aduro Biotech, Inc. (ADRO) at $202.59M represents how many People own shares of ADRO and is calculated off the last price ($2.4900) of ADRO and the quantity of shares outstanding (80.86M) with Aduro Biotech, Inc. (ADRO).
Aduro Biotech, Inc. (ADRO) has aggregate cash (mrq) of 171.13M, aggregate cash per share (mrq) of 2.11, aggregate debt of ADRO stands at 32.6M and aggregate debt/equity (mrq) is 69.92. . Aduro Biotech, Inc. (ADRO) operating cash flow (ttm) is -66.75M, ADRO leveraged free cash flow (ttm) is -42.75M.
ADRO is trading -10.35% below (bearish) its SMA20, -9.12% below (bearish) its SMA50 and 1.31% above (bullish) its SMA200.
